What will I learn about: how years of prior research on viral outbreaks like SARS, MERS, and Ebola laid the essential groundwork for the rapid development of the COVID-19 vaccine?

Discover how years of prior research on viral outbreaks like SARS, MERS, and Ebola laid the essential groundwork for the rapid development of the COVID-19 vaccine.

What will I learn about: how global health organizations learned from the shortcomings of past crises like the 2014 Ebola outbreak to better prioritize and prepare for future pandemics?

Understand how global health organizations learned from the shortcomings of past crises like the 2014 Ebola outbreak to better prioritize and prepare for future pandemics.

What will I learn about: Learn how scientists safely engineered a chimpanzee adenovirus to create a specialized vaccine vector that teaches the human body to fight viruses without causing sickness?

Learn how scientists safely engineered a chimpanzee adenovirus to create a specialized vaccine vector that teaches the human body to fight viruses without causing sickness.

What will I learn about: Explore the concept of vaccine 'platform technology,' a predesigned scientific framework that allows researchers to rapidly customize and produce vaccines for newly emerging diseases?

Explore the concept of vaccine 'platform technology,' a predesigned scientific framework that allows researchers to rapidly customize and produce vaccines for newly emerging diseases.

What will I learn about: why the Oxford-AstraZeneca COVID-19 vaccine was developed safely in record time by seeing how an earlier MERS vaccine served as its direct, ready-to-use blueprint?

Find out why the Oxford-AstraZeneca COVID-19 vaccine was developed safely in record time by seeing how an earlier MERS vaccine served as its direct, ready-to-use blueprint.

Vaxxers

The Inside Story of the Oxford AstraZeneca Vaccine and the Race Against the Virus

Sarah Gilbert and Catherine Green

★ 4.3 / 5(150 ratings)

Start ListeningDownload QR code that opens AudiobookHub on the App Store

Try free on iPhoneScan to start in 5 seconds

Categories:

Science

If You're Curious About These Questions...

You should listen to this audiobook

💡Did you know that the initial design for one of the world’s most vital vaccines was completed in just a few short days, long before the virus had even been declared a global pandemic?
💡Have you ever wondered what it’s truly like to lead a high-stakes race against time while the entire world watches—and critiques—your every move in the lab?
💡What’s the secret to condensing a decade’s worth of vaccine development into less than a year, and how could this breakthrough prepare us for the next 'Disease X'?

Listen to Vaxxers — Free Audiobook

Loading player...

Key Takeaways from Vaxxers

✓Discover how years of prior research on viral outbreaks like SARS, MERS, and Ebola laid the essential groundwork for the rapid development of the COVID-19 vaccine.
✓Understand how global health organizations learned from the shortcomings of past crises like the 2014 Ebola outbreak to better prioritize and prepare for future pandemics.
✓Learn how scientists safely engineered a chimpanzee adenovirus to create a specialized vaccine vector that teaches the human body to fight viruses without causing sickness.
✓Explore the concept of vaccine 'platform technology,' a predesigned scientific framework that allows researchers to rapidly customize and produce vaccines for newly emerging diseases.
✓Find out why the Oxford-AstraZeneca COVID-19 vaccine was developed safely in record time by seeing how an earlier MERS vaccine served as its direct, ready-to-use blueprint.

Learning Tools

Reinforce what you learned from Vaxxers

Mind Map

Vaxxers

Foundation & Preparation+

ChAdOx1 Vaccine Technology+

Rapid COVID-19 Development+

Scaling & Distribution+

Rigorous Clinical Testing+

Preparing for Disease Y+

Quiz — Test Your Understanding

Question 1 of 7

Why was a vaccine for the 2002 SARS outbreak never fully developed and distributed?

A. The virus mutated too quickly for the technology of the time.
B. Public health efforts contained the virus, eliminating the demand for a vaccine.
C. The genetic sequence of the virus was never shared by international scientists.
D. The virus only infected animals and never successfully jumped to humans.

Question 2 of 7

What is the primary advantage of the 'platform technology' (like the ChAdOx1 framework) developed by the Oxford scientists?

A. It allows researchers to create a predesigned vaccine framework that can be rapidly adapted for new viruses.
B. It uses live, replicating viruses to create a stronger, lifelong immune response in patients.
C. It eliminates the need for human clinical trials by simulating immune responses on computers.
D. It specifically targets the DNA of bats and camels to stop viruses before they jump to humans.

Question 3 of 7

How were the Oxford scientists able to design the exact DNA sequence for the COVID-19 vaccine in less than two days?

A. They already had the exact genetic code for COVID-19 from a previous outbreak in 2018.
B. They bypassed standard regulatory procedures that usually delay the initial design phase.
C. They inserted the newly released genetic sequence of the virus's spike protein into their existing MERS vaccine framework.
D. They used artificial intelligence to instantly generate a synthetic virus structure.

Question 4 of 7

In the context of the Oxford COVID-19 vaccine's development, what did it mean for the scientists to proceed 'at risk'?

A. They skipped animal testing to move directly into human clinical trials.
B. They accepted a lower standard of safety and efficacy to get the vaccine to the public faster.
C. They exposed healthy volunteers to the live virus to see if the vaccine worked.
D. They started subsequent development steps before previous testing was fully completed, risking time and funding if a step failed.

Question 5 of 7

Aside from the scale of manufacturing, what was a major logistical advantage of the Oxford-AstraZeneca vaccine compared to many other COVID-19 vaccines?

A. It only required a single dose for maximum effectiveness.
B. It could be stored and transported at normal refrigerator temperatures, making it globally accessible.
C. It could be administered orally, eliminating the need for trained nurses and syringes.
D. It was completely exempt from patent laws, allowing any country to manufacture it for free.

Question 6 of 7

What was the primary purpose of conducting animal trials for the COVID-19 vaccine before moving to human trials?

A. To ensure the vaccine did not cause a worse infection when the recipient was later exposed to the actual virus.
B. To determine the exact dosage that would be required for the Phase III human trials.
C. To test whether the vaccine could cure animals that were already suffering from severe respiratory symptoms.
D. To see if the chimpanzee adenovirus would cause cold symptoms in different mammalian species.

Question 7 of 7

According to the book's conclusion, which of the following is identified as a potential source for 'Disease Y' (a future hypothetical virus)?

A. The melting of permafrost releasing ancient pathogens.
B. Industrial farming practices that keep animals in unsanitary conditions.
C. The widespread use of antibiotics leading to vaccine-resistant bacteria.
D. The accidental release of replication-deficient viruses from research facilities.

Vaxxers — Full Chapter Overview

1Recommendation
2Scientists had been studying viral outbreaks and creating vaccines long before COVID-19 emerged.
3Progress on an Ebola vaccine opened the door to more advanced vaccine technology.
4The ChAdOx1 MERS vaccine became the model for the SARS-CoV-2 vaccine.
5Moving from one step to the next “at risk” dramatically shortened the timeline for creating the COVID-19 vaccine.
6Teaming up with AstraZeneca and others delivered the money and infrastructure to produce hundreds of millions of vaccine doses.
7Careful, extensive trials guaranteed the vaccine was safe and effective before it reached the public.
8To get ready for Disease Y, the world must strengthen research and manufacturing, public health systems, and global collaboration.

Vaxxers Summary & Overview

Vaxxers (2021) follows the race to develop a functional vaccine to curb the spread of the COVID-19 virus. Professor Sarah Gilbert and Dr. Catherine Green, of the University of Oxford, deliver captivating and informative insight into the process of designing, testing, and manufacturing the Oxford-AstraZeneca vaccine in record time. They recount exciting moments of innovation, as well as the hurdles faced along the way.

Who Should Listen to Vaxxers?

Anyone fascinated by vaccine development
Public health enthusiasts
Futurists looking to prepare for the next big pandemic

About the Author: Sarah Gilbert and Catherine Green

Professor Sarah Gilbert is Saïd Professor of Vaccinology at the University of Oxford and the co-founder of Vaccitech, a biotechnology company which develops vaccines and immunotherapies. Professor Gilbert specializes in developing vaccines for various viruses, including influenza, and co-developed the Oxford-AstraZeneca COVID-19 vaccine. This is her first book.

Dr. Catherine Green is Associate Professor in Chromosome Dynamics at the University of Oxford’s Wellcome Centre for Human Genetics. Along with Professor Gilbert, Dr. Green also worked on developing the Oxford-AstraZeneca COVID-19 vaccine. Though she is the author of numerous research studies, this is her first book.

Vaxxers

If You're Curious About These Questions...

Listen to Vaxxers — Free Audiobook

Key Takeaways from Vaxxers

Learning Tools

Mind Map

Quiz — Test Your Understanding

Vaxxers — Full Chapter Overview

Vaxxers Summary & Overview

Who Should Listen to Vaxxers?

About the Author: Sarah Gilbert and Catherine Green

Books Similar to Vaxxers